2-Cyanoethylurea is a chemical compound with the formula C4H6N2O. It is a white solid that is soluble in water. 2-Cyanoethylurea is synthesized by the reaction of urea with acrylonitrile. It has been investigated as a potential agricultural herbicide, and its effects on plants and insects are being studied. 2-Cyanoethylurea is also a component of some industrial products.'
2-cyanoethylurea: immunopotentiator [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 96033 |
| SCHEMBL ID | 3967703 |
| MeSH ID | M0102718 |
| Synonym |
|---|
| 2-cyanoethylurea |
| nsc49062 |
| ba 1-4 |
| 6640-70-6 |
| nsc-49062 |
| urea, (2-cyanoethyl)- |
| nsc 49062 |
| 2-cyanethylcarbamide |
| (2-cyanoethyl)urea |
| ba1-4 |
| unii-qa7p2myy6m |
| qa7p2myy6m , |
| urea, n-(2-cyanoethyl)- |
| AKOS011945470 |
| SCHEMBL3967703 |
| DTXSID60216625 |
| 2-cyano-ethyl urea |
| Excerpt | Relevance | Reference |
|---|---|---|
| " Lithium carbonate shows a significant increase of leukocytes in peripheral blood in dependence of dosage and frequency of applications." | ( [Effect of 2-cyanoethylurea, thymus extract and lithium carbonate on the leukocyte count in peripheral blood following whole body irradiation]. Kehrberg, G; Rose, H; Saul, G, 1986) | 0.66 |
| " Lithium-carbonate shows a significant increase of leucocytes in peripheral blood in dependence of dosage and frequency of application." | ( [Modification of radiogenic leukopenia]. Kehrberg, G; Rose, H; Saul, G, 1987) | 0.27 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.88) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||